Videos

In this episode title, ‘Shifting Epidemiology and Risk Factors in Colorectal Cancer,’ the moderator introduces the evolving landscape of colorectal cancer screening and highlights the growing importance of early detection.

Genevieve Neal-Perry, MD, PhD, discusses how elinzanetant (Lynkuet) improves sleep quality and menopause-related quality of life through its dual neurokinin receptor antagonism.

Genevieve Neal-Perry, MD, PhD, explains how rapid onset of symptom relief with elinzanetant (Lynkuet) may improve patient satisfaction and adherence.

CROI 2026: Phase III data show once-daily Eslatravir/Ravin matches BFTAF in treatment‑naive HIV, achieving high viral suppression at 48 weeks.

HIV specialist Jürgen Rockstroh, MD, discusses the importance of PrEP being more accessible through primary care physicians.

Genevieve Neal-Perry, MD, PhD, reviews the design and pooled efficacy results of the OASIS 1 and OASIS 2 trials evaluating elinzanetant (Lynkuet) for moderate to severe vasomotor symptoms.

Genevieve Neal-Perry, MD, PhD, discusses the profound impact of vasomotor symptoms on quality of life during menopause and highlights racial disparities that disproportionately affect African American women.

Explore new epinephrine options—nasal spray and sublingual film—designed to boost carry-and-use rates and treat anaphylaxis faster.

Learn severe anaphylaxis warning signs, key risk factors and how to recognize infant reactions—plus when to use epinephrine and seek ER care.

Learn why epinephrine stops anaphylaxis fast, when a second dose matters, and who can safely monitor at home after treatment.

New anaphylaxis guidance shifts care toward rapid epinephrine, fewer steroids and antihistamines, and smarter ED decisions for children and adults.

New anaphylaxis guidance urges early recognition, epinephrine-first treatment, and smarter referrals.

With <5% of health spending going to primary care, gaps in access may worsen hospital use, burnout, and chronic disease outcomes.

Cardiologist Payal Kohli, MD, emphasizes the need to address racial and ethnic disparities in CKD screening, particularly among African Americans, Hispanics, women, and older adults.

ACP’s Carney urges primary care physicians to drop “provider,” saying American College of Physicians sees it eroding trust, ethics, and physician identity.

Cardiologist Payal Kohli, MD, discusses why relying on eGFR alone may miss early kidney and cardiovascular risk.

Gus Alva, MD, outlines challenges and opportunities, including stigma reduction, substance use counseling, and practical approaches that support patients.

Physician researcher Fendrick offers an expert perspective on why removing cost barriers matters, and why navigation and patient realities still determine whether CRC screening succeeds.

Dr Hatfield shares a case of a patient living in shared housing who was concerned about her housemates seeing her PrEP medication.

Amesh Adalja, MD, infectious disease physician, outlines effective communication strategies that respect patient concerns while reinforcing physician credibility.

Multiple lab options can lead to incorrect UACR testing. Clear ordering practices are essential for actionable results.

Gus Alva, MD, previews 2026 research directions and explains why sleep assessment and sleep disorders may become a bigger focus in routine care.

Gus Alva, MD, reviews the current clinical research landscape for psychedelics and discusses how PCPs can effectively counsel patients on safety and expectations.

Psychiatrist Gus Alva, MD, discusses newer, faster depression screening approaches that primary care clinicians can implement.

From staff training to scheduling flexibility, a primary care physician shares practical insights on integrating long-acting injectable PrEP into routine care.

A nephrology expert reviews how workflow constraints and care delivery pressures affect adherence to guideline-recommended responses to elevated urine albumin-to-creatinine ratio.

A nephrology expert discusses survey findings that reveal gaps between UACR testing and action in cardiovascular risk assessment for type 2 diabetes.

Long-acting HIV prevention options simplify adherence, reduce stigma, and empower individuals to maintain their health without daily reminders.

Injection anxiety and concerns about side effects are common. A primary care physician outlines practical counseling strategies, expectation-setting, and interventions that improve patient comfort and confidence.

Real-world patient cases illustrating how pill burden, privacy, and individual preferences influence PrEP selection and adherence.